Evidence map›Paper›PMID 19652693›Full record

ArticleCancer therapy2009

Stress sensor Gadd45 genes as therapeutic targets in cancer.

Alexandra Cretu, Xiaojin Sha, Jennifer Tront, Barbara Hoffman, Dan A Liebermann

Open access · greenAbstract read
In one paragraph

Article in Cancer therapy, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Article
  3. Genes Associated with Apoptosis in an Experimental Breast Cancer Model.International journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Potential Role of microRNAs in Response toArchives of Razi Institute · 2023
    Review
  7. Article
  8. Article
  9. Lipopolysaccharide Enhances Genotoxicity by Activating GADD45G and NF-Oxidative medicine and cellular longevity · 2022
    Article
  10. Gadd45 in DNA Demethylation and DNA Repair.Advances in experimental medicine and biology · 2022
    Article
  11. GADD45 in Stress Signaling, Cell Cycle Control, and Apoptosis.Advances in experimental medicine and biology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Immunogenetic effects of low dose (CEM43 30) magnetic nanoparticle hyperthermia and radiation in melanoma cells.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alexandra CretuFels Institute for Cancer Research and Molecular Biology, and Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA, 19140 USA.
Xiaojin Sha
Jennifer Tront
Barbara Hoffman
Dan A Liebermann
Temple University · US

Funding

NEGATIVE REGULATORS OF MYELOPOIESISR01CA081168 · NCI · TEMPLE UNIV OF THE COMMONWEALTH · PI HOFFMAN, BARBARA · 1999 to 2009
$2.4M
Gadd 45 genes sensors of stress and tumor modulatorsR01CA122376 · NCI · TEMPLE UNIV OF THE COMMONWEALTH · PI LIEBERMANN, DAN A · 2007 to 2011
$1.6M
Gadd 45 in the Response of Hematopoietic Cells to StressR01HL084114 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI LIEBERMANN, DAN A · 2007 to 2010
$1.5M
NCI NIH HHS R01 CA081168NCI NIH HHS R01 CA122376NHLBI NIH HHS R01 HL084114
6 · The paper itself

Abstract

Gadd45 genes have been implicated in stress signaling responses to various physiological or environmental stressors, resulting in cell cycle arrest, DNA repair, cell survival and senescence, or apoptosis. Evidence accumulated up to date suggests that Gadd45 proteins function as stress sensors, mediating their activity through a complex interplay of physical interactions with other cellular proteins that are implicated in cell cycle regulation and the response of cells to stress. These include PCNA, p21, cdc2/cyclinB1, and the p38 and JNK stress response kinases. Disregulated expression of Gadd45 has been observed in multiple types of solid tumors as well as in hematopoietic malignancies. Also, evidence has accumulated that Gadd45 proteins are intrinsically associated with the response of tumor cells to a variety of cancer therapeutic agents. Thus, Gadd45 proteins may represent a novel class of targets for therapeutic intervention in cancer. Additional research is needed to better understand which of the Gadd45 stress response functions may be targeted for chemotherapeutic drug design in cancer therapy.

Identifiers

PMID19652693
PMCPMC2696386
OpenAlexW1516797134

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.